Publicaciones (48) Publicaciones de NURIA ERITJA SANCHEZ

2024

  1. Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review

    Cancers, Vol. 16, Núm. 1

2023

  1. Molecular Pathology of Endometrial Tumors

    Molecular Surgical Pathology: Second Edition (Springer International Publishing), pp. 297-321

2022

  1. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma

    Molecular Oncology, Vol. 16, Núm. 11, pp. 2235-2259

  2. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

  3. Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition

    Scientific Reports, Vol. 12, Núm. 1

  4. M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors

    British Journal of Cancer

  5. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2021

  1. Autophagy in the physiological endometrium and cancer

    Autophagy, Vol. 17, Núm. 5, pp. 1077-1095

  2. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  3. Endometrial pten deficiency leads to smad2/3 nuclear translocation

    Cancers, Vol. 13, Núm. 19

2020

  1. Intratumour heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification: a descriptive study

    Histopathology, Vol. 76, Núm. 3, pp. 447-460

  2. Small-molecule inhibitors (Smis) as an effective therapeutic strategy for endometrial cancer

    Cancers, Vol. 12, Núm. 10, pp. 1-26

  3. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

2019

  1. Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma

    Virchows Archiv, Vol. 474, Núm. 5, pp. 585-598

  2. Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

    Gynecologic Oncology, Vol. 153, Núm. 2, pp. 425-435

  3. Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85

2018

  1. High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition

    Phytochemistry Reviews, Vol. 17, Núm. 2, pp. 195-209

  2. Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences

    Pathobiology, Vol. 85, Núm. 1-2, pp. 35-40

2017

  1. A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium

    Cell Death and Differentiation, Vol. 24, Núm. 8, pp. 1443-1458

  2. Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy, Vol. 13, Núm. 3, pp. 608-624